Supplements
The Lens Replacement Journey
Thomas Kohnen
Published: Monday, February 1, 2021
In this supplement, published by EuroTimes in association with the ESCRS Education Forum, experts share their perspectives on optimizing MGD diagnosis and treatment. The supplement includes insights from Thomas Kohnen, Germany; Arthur Cummings, Ireland; Francesco Carones, Italy; and Detlev R.H. Breyer, Germany. Supported by an unrestricted educational grant from Alcon (Gold) and BVI (Bronze).
Tags: MGD Diagnosis
Latest Articles
A New High for Hyperopia
Hyperopia patients can expect a rise in the array of treatments.
Research Committee is Engine Driving the Future of ESCRS
Commitment to evidence-based medicine anchors studies and other projects.
ESCRS EPICAT Study Updates
Early results suggest subconjunctival 10 mg triamcinolone an effective strategy for dropless cataract surgery.
Second Global Consensus on Keratoconus
Forthcoming position paper to provide an updated and expanded view on evaluation and management.
Know Thy Enemy
Education for All Is What Makes ESCRS Unique
Surgeons Split on Post-Surgery Inflammation Control
Leading surgeons weigh whether or how to use a dropless regimen after cataract surgery.
Thinking of Selling Your Practice?
Planning an exit strategy is best begun early in your career.